Newcardio Inc (NWCI)
0.00
USD |
OTCM |
May 22, 16:00
Newcardio Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2011 | 0.5664M |
| June 30, 2011 | 0.6926M |
| March 31, 2011 | 0.7246M |
| December 31, 2010 | 0.911M |
| September 30, 2010 | 0.7484M |
| June 30, 2010 | 1.038M |
| March 31, 2010 | 0.8881M |
| December 31, 2009 | 0.7094M |
| September 30, 2009 | 0.7962M |
| June 30, 2009 | 0.7495M |
| Date | Value |
|---|---|
| March 31, 2009 | 0.7929M |
| December 31, 2008 | 0.8458M |
| September 30, 2008 | 0.6737M |
| June 30, 2008 | 0.3215M |
| March 31, 2008 | 0.2851M |
| December 31, 2007 | 0.3175M |
| September 30, 2007 | 0.0099M |
| June 30, 2007 | 0.0389M |
| March 31, 2007 | 0.0034M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 7.452M |
| Retractable Technologies Inc | 0.1423M |
| Xtant Medical Holdings Inc | 0.527M |
| Asensus Surgical Inc | 8.091M |
| Catheter Precision Inc | 0.037M |